日本小林製藥紅麴問題：死亡個案可能增至76人

Reported 9 months ago

日本厚生勞動省收到79人服用小林製藥問題紅麴保健食品後死亡的報告，其中有3人的死亡被認定與食品無關，餘下的76人仍在調查中。報導指出，至今小林製藥公布的死亡人數為5人。許多服用後出現腎臟問題的民眾顯示疑似與尿細管損傷有關的症狀和檢查結果。

You may also interested in these wikis

Morgan Stanley Plans to Lay Off 2,000 Employees to Cut Costs

Redburn Issues 'Sell' Rating for Reddit, Citing Google Algorithm Risks

Chinese Stocks Gaining Attention as US Exceptionalism Wanes

Bitcoin Falls Below $90K: Traders Expect 'Max Pain' Before Recovery

Investors Await Optimism from Nvidia CEO's Keynote

Corporate Exodus to Texas: A New Business Hub Emerges

Federal Reserve's Dilemma Amid Trump's Tariffs and Market Uncertainty

Strategist Advises on Bond Duration Amid Economic Uncertainty

Tesla Stock Declines Amid Free Self-Driving Trial in China

Fund Managers Embrace Defense Investments Once Considered Unthinkable

Back to all Wikis